Pseudomyogenic Hemangioendothelioma Treated with Zoledronic Acid
This case highlights a durable radiographic and clinical response to zoledronic acid monotherapy in multifocal pseudomyogenic hemangioendothelioma, supporting its role as a function-preserving systemic therapy.
Authors
- Nam Q. Bui (ORCID: https://orcid.org/0000-0001-6896-4349)
- Gregory W. Charville (ORCID: https://orcid.org/0000-0002-2774-2704)
- Kip E. Guja (ORCID: https://orcid.org/0000-0002-9549-7085)
- A McGovern (ORCID: https://orcid.org/0009-0001-1566-557X)
- Robert J. Steffner (ORCID: https://orcid.org/0000-0001-9223-2770)
Institutions
- Stanford University (US)
Publication Details
- Journal
- JBJS Case Connector
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2106/jbjs.cc.25.00396
- Primary Topic
- Vascular Tumors and Angiosarcomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00